Glenn Sblendorio is President and Chief Executive Officer and a member of the Board of Directors of Ophthotech. He joined Ophthotech in 2016 as Executive Vice President, Chief Operating Officer and Chief Financial Officer and was appointed President in January 2017 while continuing to serve as Chief Financial Officer. Prior to joining Ophthotech, he served as President and Chief Financial Officer and member of the Board of Directors of The Medicines Company. Prior to The Medicines Company, Mr. Sblendorio served as Executive Vice President and Chief Financial Officer of Eyetech. His pharmaceutical experience also includes 12 years at Hoffmann-LaRoche in a variety of senior financial positions. Mr. Sblendorio currently serves on the Board of Directors of Amicus Therapeutics and Intercept Pharmaceuticals.